Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
Categories
How Patient Support Programs Can Compliantly Interact with Commercial Teams
With the right approach, patient support programs can mitigate the potential negative impacts of regulatory compliance
Effective and Practical Ways to Impact Health Inequity Now
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
Want to Build a Market-Leading Pharmaceutical Patient Support Program? Ask a Nurse.
In celebration of Nurses Day, explore how nurses working for pharmaceutical consulting companies benefit manufacturers’ commercial goals
11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
The answers to these eleven questions will help guide commercial teams in effectively launching specialty products.
How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking alternative avenues.
Maximizing Specialty Pharmacy Contracts
When approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
What the CMS Final Rule on Copay Programs Means for Pharmaceutical Manufacturers
It is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
Rare Disease Resources Every Pharma and Biotech Company Should Know
We often advise our clients that there are many varied ways to better understand and engage with rare disease patients.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|